Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Emricasan

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Histogen and Amerimmune Announce Positive Results for Emricasan
    Histogen and Amerimmune Announce Positive Results for Emricasan

    22 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/22/2250903/0/en/Histogen-and-Amerimmune-Announce-Positive-Top-Line-Study-Results-from-its-Phase-1-Study-of-Emricasan-in-Mild-Symptomatic-COVID-19-Patients.html

    GLOBENEWSWIRE
    22 Jun 2021
    Share Share
    Conatus wields ax as Novartis-partnered NASH drug fails again
    Conatus wields ax as Novartis-partnered NASH drug fails again

    26 Jun 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/conatus-wields-ax-as-novartis-partnered-nash-drug-fails-again

    Nick P. Taylor FIERCE BIOTECH
    26 Jun 2019
    Share Share
    Conatus grabs the ax and packs it in on NASH after a series of setbacks
    Conatus grabs the ax and packs it in on NASH after a series of setbacks

    24 Jun 2019

    // John Carroll ENDPTS

    https://endpts.com/suffering-novartis-partner-conatus-is-packing-it-in-on-nash-after-a-series-of-unfortunate-trial-events/

    John Carroll ENDPTS
    24 Jun 2019
    Share Share
    Novartis Inks Deal With Conatus Pharma For Chronic Liver Diseases
    Novartis Inks Deal With Conatus Pharma For Chronic Liver Diseases

    20 Dec 2016

    // NASDAQ

    http://www.nasdaq.com/article/novartis-inks-deal-with-conatus-pharma-for-chronic-liver-diseases-20161219-01011

    NASDAQ
    20 Dec 2016
    Share Share
    Conatus liver drug shows promise in mid-stage trial
    Conatus liver drug shows promise in mid-stage trial

    05 Jan 2016

    // Shailesh Kuber REUTERS

    http://www.reuters.com/article/us-conatus-trial-idUSKBN0UJ25U20160105

    Shailesh Kuber REUTERS
    05 Jan 2016
    Share Share